Lumakras plus Vectibix showed improved overall survival and response rates in KRAS G12C metastatic colorectal cancer, though ...

This Vectibix (panitumumab) market report delivers an in-depth analysis of the market's key characteristics, including size, growth potential, and segmentation. It provides a detailed breakdown of the ...

The US regulator has cleared Lumakras (sotorasib) in combination with Amgen's anti-EGFR antibody Vectibix (panitumumab) for adults with KRAS G12C-mutated metastatic colorectal cancer (CRC ...

Amgen has announced it has entered into an agreement with Zhejiang Beta Pharma Co., Ltd to form a joint venture to commercialise Amgen's colorectal cancer drug, Vectibix, in the Chinese market.

According to the complaint, Amgen and its affiliates “have for many years infringed the Iowa Patents with full knowledge of them” to produce Enbrel (etanercept) and Vectibix (panitumumab).

(MENAFN- GlobeNewsWire - Nasdaq) This Vectibix (panitumumab) market report delivers an in-depth analysis of the market's key characteristics, including size, growth potential, and segmentation.